Literature DB >> 3736876

Biotinidase deficiency: accumulation of lactate in the brain and response to physiologic doses of biotin.

N Diamantopoulos, M J Painter, B Wolf, G S Heard, C Roe.   

Abstract

Biotinidase deficiency is the most common cause of late onset, biotin-responsive multiple carboxylase deficiency (MCD). We studied the two oldest known boys with this disorder who had high CSF content of lactate that could have contributed to the clinical disorder. The symptoms of these patients implied that near physiologic, rather than pharmacologic, doses of biotin may be sufficient for treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3736876     DOI: 10.1212/wnl.36.8.1107

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

Review 1.  Novel roles of holocarboxylase synthetase in gene regulation and intermediary metabolism.

Authors:  Janos Zempleni; Dandan Liu; Daniel Teixeira Camara; Elizabeth L Cordonier
Journal:  Nutr Rev       Date:  2014-03-28       Impact factor: 7.110

2.  Asymptomatic adults and older siblings with biotinidase deficiency ascertained by family studies of index cases.

Authors:  T Baykal; G Gokcay; Y Gokdemir; F Demir; Y Seckin; M Demirkol; K Jensen; B Wolf
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Comparison of patients with complete and partial biotinidase deficiency: biochemical studies.

Authors:  T M Suormala; E R Baumgartner; H Wick; S Scheibenreiter; S Schweitzer
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

4.  Biotinidase deficiency-Diagnosis by enzyme assay and a follow-up study.

Authors:  N Ananth; G S Praveen Kumar
Journal:  Indian J Clin Biochem       Date:  2003-07

Review 5.  Holocarboxylase synthetase deficiency: 9-year follow-up of a patient on chronic biotin therapy and a review of the literature.

Authors:  A J Michalski; G T Berry; S Segal
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

6.  Development and characterization of a mouse with profound biotinidase deficiency: a biotin-responsive neurocutaneous disorder.

Authors:  Kirit Pindolia; Megan Jordan; Caiying Guo; Nell Matthews; Donald M Mock; Erin Strovel; Miriam Blitzer; Barry Wolf
Journal:  Mol Genet Metab       Date:  2010-10-13       Impact factor: 4.797

7.  Cerebrospinal fluid organic acids in biotinidase deficiency.

Authors:  M Duran; E R Baumgartner; T M Suormala; L Bruinvis; L Dorland; J A Smeitink; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

8.  Cerebral metabolic change after treatment in biotinidase deficiency.

Authors:  I T Lott; S Lottenberg; W L Nyhan; M J Buchsbaum
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

9.  Normalisation of severe cranial CT scan abnormalities after biotin in a case of biotinidase deficiency.

Authors:  H D Bakker; M Westra; W C Overweg-Plandsoen; G van Waveren; J H Sillevis Smitt; N G Abeling; R J Wanders; R B Schutgens; A H van Gennip
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

10.  Biotinidase Km-variants: detection and detailed biochemical investigations.

Authors:  T Suormala; V T Ramaekers; S Schweitzer; B Fowler; M C Laub; C Schwermer; J Bachmann; E R Baumgartner
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.